Isofol Medical isofolmedical.se


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Isofol Medical is a clinical stage pharmaceutical company headquartered in Gothenburg, Sweden. Its lead candidate, Modufolin, is a novel folate-based therapy developed to increase the efficacy and reduce the side effects of antimetabolites used in cancer treatment. Through a worldwide exclusive license agreement, Isofol Medical holds the rights to commercialise Modufolin with access to the patented production process and the production capabilities of Merck KGaA in Darmstadt, Germany.

Isofol Medical is a clinical stage pharmaceutical company headquartered in Gothenburg, Sweden. Its lead candidate, Modufolin, is a novel folate-based therapy developed to increase the efficacy and reduce the side effects of antimetabolites used in ca...Show all

Company (IPO / Went public)

Phone: +46 (0) 31 797 22 80

Fax:

Biotech Center
Arvid Wallgrens Backe 20
Gothenburg, SE-413 46
Sweden

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Isofol Medical $0M Apr 4, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Isofol Medical Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Tetrahydrofolates in combination with egfr-inhibitors Jan 18, 2013 Jun 13, 2017 Patent
Reduction of toxicity of multi-targeting antifolates Jul 29, 2015 Mar 07, 2017 Patent
Reduction of toxicity of multi-targeting antifolates Jul 22, 2010 Sep 22, 2015 Patent
Administration regime Jan 30, 2015 Application
Anti-tumor activity of reduced folates like methylene-tetrahydrofolate Jan 18, 2013 Application